Puma registered the highest quarterly sales in its history in the third quarter of fiscal 2022 at €2,354.4 million, up by 16.9 percent.
The Americas region posted the highest sales growth for the German sportswear giant at 18.8 percent. Sales in EMEA were up 18.5 percent, driven by growth across almost all key European markets.
For the first time this year, Asia/Pacific also recorded a sales growth, which is at 9.8 percent.
While COVID-19 lockdown measures impacted business in Greater China, other key markets in Asia/Pacific delivered strong growth.
Sales in footwear increased 33.2 percent and apparel was up 9.9 percent, driven by continued strong demand for performance categories like Running & Training, Team Sports Basketball, and Sportstyle.
Meanwhile, sales in accessories were down 10.2 percent.
The gross profit margin dropped by 60 basis points to 46.8 percent, mainly due to higher sourcing prices of raw materials.


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
‘The geezer game’ – a nearly 50-year-old pickup basketball game – reveals its secrets to longevity
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Attends Super Bowl Amid Cheers, Boos, and Political Divide
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Why the Australian Open’s online tennis coverage looks like a Wii sports game
JD Vance to Lead U.S. Presidential Delegation at Milano Cortina Winter Olympics Opening Ceremony
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
From Messi to Mika Häkkinen: how top athletes can slow down time
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



